KPTI Overview
Upcoming Projects (KPTI)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (KPTI)
-
A Second Look: Discussing Karyopharm Therapeutics Dose-Escalation Study of Selinexor Plus Ruxolitinib in Patients with Treatment-Naïve Myelofibrosis
Ticker: KPTI
Executed On: Apr 27, 2023 at 02:30 PM EDT -
Discussing Karyopharm Therapeutics Dose-Escalation Study of Selinexor Plus Ruxolitinib in Patients with Treatment-Naïve Myelofibrosis
Ticker: KPTI
Executed On: Apr 26, 2023 at 12:00 PM EDT -
A second look at the use of Carvykti(ciltacabtagene autoleucel) and Xpovio(selinexor) in multiple myeloma
Tickers: LEGN, KPTI
Executed On: Aug 24, 2022 at 03:00 PM EDT -
A look at the use of Carvykti(ciltacabtagene autoleucel) and Xpovio(selinexor) in multiple myeloma
Tickers: LEGN, KPTI
Executed On: Aug 04, 2022 at 12:00 PM EDT -
Checking on the Launch of Xpovio in relapsed refractory multiple myeloma and relapsed or refractory diffuse large B-cell lymphoma
Ticker: KPTI
Executed On: Feb 24, 2022 at 06:00 PM EST
Upcoming & Overdue Catalysts (KPTI)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (KPTI)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
